Product NDC: | 0088-1208 |
Proprietary Name: | Anzemet |
Non Proprietary Name: | dolasetron mesylate |
Active Ingredient(s): | 12.5 mg/.625mL & nbsp; dolasetron mesylate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0088-1208 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020624 |
Marketing Category: | NDA |
Start Marketing Date: | 19970911 |
Package NDC: | 0088-1208-06 |
Package Description: | 6 VIAL, SINGLE-USE in 1 BOX (0088-1208-06) > .625 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0088-1208-06 |
Proprietary Name | Anzemet |
Package Description | 6 VIAL, SINGLE-USE in 1 BOX (0088-1208-06) > .625 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0088-1208 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | dolasetron mesylate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19970911 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | DOLASETRON MESYLATE |
Strength Number | 12.5 |
Strength Unit | mg/.625mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |